[The adjuvant killing effect of modulated electro-hyperthermia combined with chemotherapy on B16F10 melanoma cells]
/in Hyperthermia, International Publications, Malignant Melanoma /von 2020-02-21 / Magy Onkol 2021 Mar;65(1):71-77Feasibility of modulated electro-hyperthermia in preoperative treatment for locally advanced rectal cancer: Early phase 2 clinical results
/in Colorectal Cancer, Hyperthermia, International Publications /von 2020-02-09 / Neoplasma 2020 May;67(3):677-683A Narrative Review of Regional Hyperthermia: Updates From 2010 to 2019
/in Hyperthermia, International Publications /von 2020-01-01 / Integr Cancer Ther 2020 Jan-Dec;19:1534735420932648Efficacy of Combination Neoadjuvant Chemotherapy and Regional Inductive Moderate Hyperthermia in the Treatment of Patients With Locally Advanced Breast Cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2020-01-01 / Technol Cancer Res Treat 2020 Jan-Dec;19:1533033820963599Heating technology for malignant tumors: a review
/in Hyperthermia, International Publications /von 2020-01-01 / Int J Hyperthermia 2020;37(1):711-741Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist
/in Hyperthermia, International Publications /von 2019-11-01 / Front Oncol 2019;9:1012Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer
/in Hyperthermia, International Publications, Ovarian Cancer /von 2019-09-01 / Jpn. J. Clin. Oncol. 2019 Sep;49(9):832-838Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects
/in Hyperthermia, International Publications, Malignant Melanoma /von 2019-08-17 / Int J Mol Sci 2019 Aug;20(16)The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial
/in Cervical Cancer, Hyperthermia, International Publications /von 2019-06-19 / PLoS ONE 2019;14(6):e0217894IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de